RNA-Lipid Nanoparticle Platform for the Multi-step engineering of gene edited CAR-T cells.

New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell TherapyПодробнее

Manufacturing RNA lipid nanoparticles to deliver high quality transformative medicinesПодробнее

CAR T Cell Therapy with a Scalable RNA Lipid Nanoparticle PlatformПодробнее

Engineering Next Generation CAR T Cells with CRISPRПодробнее

Webinar: Lipid nanoparticle LNP synthesis and CAR-T applicationПодробнее

SciTalk: From Physics to Lipid Nanoparticles to Gene TherapyПодробнее

RNA Therapeutics: Going Beyond the LiverПодробнее

A platform for automated functionalization of lipid nanoparticles for CAR T cell therapyПодробнее

How Lipid Nanoparticles (LNPs) Dutifully Deliver mRNAПодробнее

MIT.nano Seminar Series: Kathryn WhiteheadПодробнее

eTheRNA’s mRNA Lipid Nanoparticles LNP Technology Developed for its Cancer Immunotherapy ProgramsПодробнее

Transient Expression of mRNA-LNP-based Chimeric Antigen Receptors for Safe ImmunotherapyПодробнее

Polysarcosine-Functionalized Lipid Nanoparticles for Therapeutic mRNA DeliveryПодробнее

Nanomaterials and RNA engineering for mRNA therapeutics, genome editing, and cell therapyПодробнее

Insights on Lipid Nanoparticle Delivery and Scalable Microfluidic ManufacturingПодробнее

Ionizable Lipids to Optimize RNA-LNP DeliveryПодробнее

Transient Expression of mRNA Lipid Nanoparticle-based Chimeric Antigen Receptors for ImmunotherapyПодробнее

Lipid nanoparticles for RNA deliveryПодробнее